Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 64 Next >>

Filter Applied: disability rating scale,neurological (Click to remove)

Implementation of a Prehospital Stroke Triage System Using Symptom Severity and Teleconsultation in the Stockholm Stroke Triage Study
JAMA Neurol 77:691-699, Mazya, M.V.,et al, 2020

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
NEJM 378:708-718, Albers, G.W.,et al, 2018

Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
NEJM 372:1009-1018, Campbell, B.C.V.,et al, 2015

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
NEJM 372:1019-1030, Goyal, M.,et al, 2015

Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Arch Neurol 65:1024-1030, Stead,L.G.,et al., 2008

Correlation of Perfusion-and Diffusion-Weighted MRI with NIHSS Score in Acute (<6. 5 hr) Ischemic Stroke
Neurol 50:864-870, 8421998., Tong,D.C.,et al, 1998

Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 339:1105-1111, Limousin,P.,et al, 1998

Intracranial Aneurysms
NEJM 336:28-40, Schievink,W.I., 1997

Ischemic Lesion Volumes in Acute Stroke by Diffusion-Weighted MRI Correlate with Clinical Outcome
Ann Neurol 42:164-170, Lovblad,K-O.,et al, 1997

Acute Stroke:Prognosis & Prediction of Effect of Med Treat Outcome & Health Care Util, Copenhagen Study
Neurol 49:1335-1342, Jorgensen,H.S.,et al, 1997

Management of Aneurysmal Subarachnoid Hemorrhage
Stroke 19:1300-1305, Biller,J.,et al, 1988

Characteristics and Outcomes in Patients with COVID-19 and Acute Ischemic Stroke
Stroke 51:e254-e258, Ntaios, G.,et al, 2020

Cortical Superficial Siderosis Multifocality in Cerebral Amyloid Angiopathy
Neurol 89:2128-2135, Charidimou, A.,et al, 2017

The Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale
Stroke 43:2871-2876, Pescini, F.,et al, 2012

Interobserver Variability of Grading Scales for Aneurysmal Subarachnoid Hemorrhage
Stroke 42:1546-1549, Degen, L.A.R.,et al, 2011

Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS
Neurol 54:813-817, Ge,Y.,et al, 2000

Early Clinical and Radiological Predictors of Fatal Brain Swelling in Ischemic Stroke
Stroke 30:287-292, Krieger,D.W.,et al, 1999

Baseline NIH Stroke Scale Score Strongly Predicts Outcome after Stroke, A Report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
Neurol 53:126-131, Adams,Jr.,H.P.,et al, 1999

Quality of Life in Patients and Partners After Aneurysmal Subarachnoid Hemorrhage
Stroke 29:798-804, Hopp,J.W.,et al, 1998

A Prediction Model for Functional Recovery in Stroke
Stroke 28:550-556, Stineman,M.G.,et al, 1997

Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score Before Ultraearly Thrombolytic Therapy
AJNR 17:79-85, Tomsick,T.,et al, 1996

Functional Outcome in Patients with Lacunar Infarction
Stroke 27:842-846, Samuelsson,M.,et al, 1996

Utilization of Acute Care Services in the Year Before and After First Stroke:A Population-Based Study
Neurol 46:861-869, 6021996., Leibson,C.L.,et al, 1996

'Malignant'Middle Cerebral Artery Territory Infarction
Arch Neurol 53:309-315, Macke,W.,et al, 1996

Comparison of Neurological Scales and Scoring System for Acute Stroke Prognosis
Stroke 27:1817-1820, Muir,K.W.,et al, 1996

Interrater Agreement in Evaluation of Stroke Patients with the Unified Neurological Stroke Scale
Stroke 25:1263-1264, Treves,T.A.,et al, 1994

Measuring Physical Impairment and Disability with the Chedoke-McMaster Stroke Assessment
Stroke 24:58-63, Gowland,C.,et al, 1993

A Comparison of Five Stroke Scales with Measures of Disability, Handicap, and Quality of Life
Stroke 24:1178-1181, DeHaan,R.,et al, 1993

The Frenchay Activities Index, Assessment of Functional Status in Stroke Patients
Stroke 24:1173-1177, Schuling,J.,et al, 1993

Assessment of Scales of Disability and Handicap for Stroke Patients
Stroke 22:1242-1244, Wolfe,C.D.A.,et al, 1991

A Critical Appraisal of Stroke Evaluation and RAting Scales
Stroke 22:1345-1352, Lyden,P.D.&Lau,G.T., 1991

Predictors of Stroke Outcome Using Objective Measurement Scales
Stroke 21:78-81, Loewen,S.C.&Anderson,B.A., 1990

Deteriorating Ischemic Stroke:Risk Factors and Prognosis
Neurol 40:1865-1869, Davalos,A.,et al, 1990

Interrater Reliability of the NIH Stroke Scale
Arch Neurol 46:660-662, Goldstein,L.B.,et al, 1989

Interobserver Agreement for the Assessment of Handicap in Stroke Patients
Stroke 19:604-607, vanSwieten,J.C.,et al, 1988

Graded Neurologic Scale for Use in Acute Hemispheric Stroke Treatment Protocols
Stroke 18:665-669, Adams,R.J.,et al, 1987

Acute Spinal Cord Compression
NEJM 376:1358-1369, Ropper, A.E. & Ropper, A.H., 2017

Gray Matter Involvement in Multiple Sclerosis
Neurol 68:634-642, Pirko,I.,et al, 2007

MRI T2 Lesion Burden in Multiple Sclerosis. A Plateauing Relationship with Clinical Disability.
Neurol 66:1384-1389, Li,D.K.B.,et al, 2006

Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002

A Longitudinal Study of Abnormalities on MRI and Disability From Multiple Sclerosis
NEJM 346:158-164,199, Brex,P.A.,et al, 2002

Functional Recovery After Rehabilitation for Cerebellar Stroke
Stroke 32:530-534, Kelly,P.J.,et al, 2001

Neurologic Manifestations of HIV Infection
Ann Int Med 121:769-785, Simpson,D.M.&Tagliati,M., 1994

Survival of Implanted Fetal Dopamine Cells & Neuro Improvement 12 to 46 Months after Transpl for Parkinson's
NEJM 327:1549-1555, 15891992., Freed,C.R.,et al, 1992

Cortical Pathology in Multiple Sclerosis Patients with Epilepsy: A 3 Year Longitudinal Study
JNNP 83:49-54, Calabrese, M.,et al, 2012

Cortical Lesions in Primary Progressive Multiple Sclerosis: A 2-Year Longitudinal MR Study
Neurol 72:1330-1336, Calabrese,M.,et al, 2009

The Alcohol Withdrawal Syndrome
JNNP 79:854-862, McKeon,A.,et al., 2008

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007



Showing articles 0 to 50 of 64 Next >>